Please provide your email address to receive an email when new articles are posted on . GLP-1RAs may help reduce risk for adverse liver outcomes in alcohol-associated liver disease and diabetes.

Although diabetes is a common condition, no cure exists yet. Current therapies can manage blood sugar levels, but they do not address insulin resistance. But now, recent research reported in ACS Nano ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how diabetes-associated sleep fragmentation impairs liver and heart function via SIRT1-dependent epigenetic modulation of NADPH ...

More than half of all people with type 2 diabetes have steatotic (or fatty) liver disease, but most do not realize it since liver disease rarely causes any symptoms in the earlier stages. Over time, ...

Clinicians should screen adults with type 2 diabetes or prediabetes for nonalcoholic fatty liver disease (NAFLD), according to a guideline update to the American Diabetes Association’s Standards of ...

Share on Pinterest Semaglutide may be effective in treating a form of fatty liver disease, new research shows. Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that can ...

Please provide your email address to receive an email when new articles are posted on . Insulin resistance is associated with both diabetes and nonalcoholic fatty liver disease. Reducing sugar intake ...

A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer. Hepatocellular carcinoma, a type of ...

SAN DIEGO — The American Diabetes Association (ADA) now advises universal screening of people with type 2 diabetes and prediabetes for fatty liver disease and provides new recommendations for ...